- Home
- XGN vs AFCG Comparison
XGN vs AFCG Comparison
Compare XGN & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XGN | AFCG |
|---|---|---|
| Founded | 2002 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.2M | 70.4M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XGN | AFCG |
|---|---|---|
| Price | $3.65 | $3.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $8.86 | $4.50 |
| AVG Volume (30 Days) | ★ 365.2K | 221.5K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 6.94% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $24,563,601.00 |
| Revenue This Year | $8.12 | $1,334.03 |
| Revenue Next Year | $13.00 | $17.33 |
| P/E Ratio | ★ N/A | $6.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.59 | $2.06 |
| 52 Week High | $12.23 | $5.87 |
Technical Indicators
Market Signals| Indicator | XGN | AFCG |
|---|---|---|
| Relative Strength Index (RSI) | 61.64 | 67.87 |
| Support Level | $3.15 | $3.20 |
| Resistance Level | $3.89 | $3.35 |
| Average True Range (ATR) | 0.27 | 0.15 |
| MACD | 0.10 | 0.03 |
| Stochastic Oscillator | 62.91 | 77.41 |
Price Performance
Historical ComparisonAbout XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.